JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
KVSC
2526
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
| $6.39M | ﹤0.01% |
+629,477
| New | +$6.35M |
2023 Q1
0 quarters
|
|
2527
Texas Capital Bancshares
TCBI
$4.04B
| $6.38M | ﹤0.01% |
130,299
+28,783
| +28% | +$1.77M |
2013 Q2
39 quarters
|
|
2528
Bank of Hawaii
BOH
$2.65B
| $6.36M | ﹤0.01% |
122,139
+15,652
| +15% | +$1.1M |
2013 Q2
39 quarters
|
|
2529
Integer Holdings
ITGR
$4.3B
| $6.34M | ﹤0.01% |
81,862
+11,491
| +16% | +$842K |
2013 Q2
39 quarters
|
|
|
MEKA
2530
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
| $6.33M | ﹤0.01% |
620,881
+249,795
| +67% | +$2.54M |
2021 Q3
6 quarters
|
|
2531
Dimensional International Core Equity 2 ETF
DFIC
$15.2B
| $6.33M | ﹤0.01% |
263,027
+51,265
| +24% | +$1.22M |
2022 Q4
1 quarter
|
|
2532
Invesco FTSE RAFI US 1000 ETF
PRF
$9.95B
| $6.32M | ﹤0.01% |
201,670
+64,265
| +47% | +$2.04M |
2018 Q3
18 quarters
|
|
2533
InterDigital
IDCC
$8.76B
| $6.31M | ﹤0.01% |
86,604
+32,840
| +61% | +$2.29M |
2013 Q2
39 quarters
|
|
2534
Genmab
GMAB
$23.2B
| $6.3M | ﹤0.01% |
166,747
-32,546
| -16% | -$1.25M |
2019 Q3
14 quarters
|
|
2535
Corcept Therapeutics
CORT
$12.8B
| $6.29M | ﹤0.01% |
290,592
+48,146
| +20% | +$1.06M |
2016 Q4
25 quarters
|
|
2536
Titan Machinery
TITN
$600M
| $6.29M | ﹤0.01% |
206,722
-12,241
| -6% | -$499K |
2015 Q4
29 quarters
|
|
2537
Business First Bancshares
BFST
$1B
| $6.28M | ﹤0.01% |
366,814
+100,277
| +38% | +$2M |
2018 Q2
19 quarters
|
|
2538
Kura Oncology
KURA
$939M
| $6.28M | ﹤0.01% |
513,222
-691
| -0.1% | -$8.62K |
2017 Q3
22 quarters
|
|
2539
CALL
International Paper
IP
$17B
| $6.27M | ﹤0.01% |
173,900
+26,493
| +18% | +$981K |
2021 Q3
6 quarters
|
|
2540
PUT
Carlyle Group
CG
$13.9B
| $6.21M | ﹤0.01% |
200,000
+182,100
| +1,017% | +$6.08M |
2022 Q4
1 quarter
|
|
|
NATI
2541
PUT
DELISTED
National Instruments Corp
NATI
| $6.21M | ﹤0.01% |
+118,500
| New | +$5.94M |
2023 Q1
0 quarters
|
|
2542
WisdomTree Bloomberg US Dollar Bullish Fund
USDU
$293M
| $6.21M | ﹤0.01% |
238,230
+24,152
| +11% | +$630K |
2022 Q2
3 quarters
|
|
2543
Strategic Education
STRA
$1.76B
| $6.19M | ﹤0.01% |
68,953
-1,598
| -2% | -$141K |
2013 Q2
39 quarters
|
|
2544
PUT
Marathon Petroleum
MPC
$122B
| $6.19M | ﹤0.01% |
45,900
-188,100
| -80% | -$23.5M |
2021 Q3
6 quarters
|
|
2545
AXIS Capital
AXS
$7.01B
| $6.19M | ﹤0.01% |
113,435
-2,841
| -2% | -$165K |
2013 Q2
39 quarters
|
|
2546
XPEL
XPEL
$1.24B
| $6.18M | ﹤0.01% |
90,951
+65,820
| +262% | +$4.64M |
2020 Q2
11 quarters
|
|
2547
PUT
Target
TGT
$70B
| $6.16M | ﹤0.01% |
37,200
-15,700
| -30% | -$2.58M |
2021 Q3
6 quarters
|
|
|
UCTT
2548
Ultra Clean Holdings
UCTT
$3.28B
| $6.16M | ﹤0.01% |
185,641
+18,217
| +11% | +$602K |
2013 Q2
39 quarters
|
|
2549
Invesco Dorsey Wright Momentum ETF
PDP
$1.51B
| $6.15M | ﹤0.01% |
80,977
-872
| -1% | -$64.9K |
2013 Q2
39 quarters
|
|
|
JLQD
2550
Janus Henderson Corporate Bond ETF
JLQD
$15.6M
| $6.15M | ﹤0.01% |
148,376
-324
| -0.2% | -$13.3K |
2021 Q3
6 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.